Andrew Galligan

Andrew Hugh Galligan is currently a Director at Nevro Medical Ltd. since 2010, an Independent Director at Ooma, Inc. since 2014, and a Fellow at The Institute of Chartered Accountants in Ireland.
Former roles include Director at diaDexus, Inc., Independent Director at Arcellx, Inc. from 2025 to 2026, Independent Director at Diadexus, Inc. from 2011 to 2015, Chief Financial Officer & Vice President at Molecular Devices LLC, Lumisys, Inc., Corcept Therapeutics, Inc., Amira Medical, Inc., IPS Health Care, Inc., and Chief Financial Officer & Vice President-Finance at Reliant Technologies, Inc. from 2007 to 2008, Ooma, Inc. from 2009 to 2010, and Nevro Corp.
from 2010 to 2020.
Chief Financial Officer at Metrika, Inc. from 2003 to 2011.
Education includes undergraduate studies at Trinity College Dublin.